Functionally, miR-34a targets N-MYC[100], while miR-184 targets AKT and orchestrates their tumor-suppressive function[102], miR-34a induces cell cycle arrest and apoptosis activation in NB cells[103]. The gene discussed is MYCN; the disease is neuroblastoma.